3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Conditions
Multiple Sclerosis
2
Carcinoma in Situ
2
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis, Chronic Progressive
1
Interventions
valrubicin
3
dodecyl maltoside
3
Mitomycin
2
Interferon beta-1b
2
Gemcitabine
2
pembrolizumab
1
enfortumab vedotin
1
cemiplimab
1
apaziquone
1
Standard of Care
1
Oncolytic Virotherapy
1
Interferons
1
Imiquimod
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
BCG Vaccine
1
ALT-801
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Carcinoma in Situ
×
Interferon beta-1b
×
Clear all
NCT02486640
2023-07-24
BETAPREDICT
Bayer
Completed
162 enrolled
NCT03134573
2019-03-26
PROmyBETAapp
Bayer
Completed
96 enrolled